We are live on ! Find out more
IMA

ImageneBio Inc
IMA

33 hedge funds and large institutions have $38.3M invested in ImageneBio Inc in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.02% more ownership

Funds ownership: 6.32% → 11.34% (+5%)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

10% less capital invested

Capital invested by funds: $42.6M → $38.3M (-$4.21M)

18% less funds holding

Funds holding: 40 → 33 (-7)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
33
Holders Change
-7
Holders Change %
-17.5%
% of All Funds
0.43%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
5
Increased
14
Reduced
13
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$8.87M
2
BI
BVF Inc
California
+$6.21M
3
RI
RTW Investments
New York
+$4.43M
4
OFM
Omega Fund Management
Massachusetts
+$3.55M
5
BOCH
Blue Owl Capital Holdings
New York
+$2.65M

Top Sellers

Rank Fund Capital Flow
1
BCM
BML Capital Management
Indiana
-$2.03M
2
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$535K
3
GS
Gilead Sciences
California
-$467K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$278K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$193K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
26
Tower Research Capital (TRC)
New York
$7.15K +$9.11K +687 +362%
Federated Hermes
27
Federated Hermes
Pennsylvania
$1.66K +$2.7K +204 New
JP Morgan Chase
28
JP Morgan Chase
New York
$571 -$13 -1 -1%
Fidelity Investments
29
Fidelity Investments
Massachusetts
$546 +$888 +67 New
Wells Fargo
30
Wells Fargo
California
$334 -$13 -1 -2%
Bank of America
31
Bank of America
North Carolina
$212 -$265 -20 -43%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$196 -$27 -2 -8%
GS
33
Gilead Sciences
California
– -$467K -29,045 Closed
Acadian Asset Management
34
Acadian Asset Management
Massachusetts
– -$278K -17,464 Closed
Two Sigma Advisers
35
Two Sigma Advisers
New York
– -$193K -12,008 Closed
State Street
36
State Street
Massachusetts
– -$123K -7,679 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$89.3K -5,555 Closed
Two Sigma Investments
38
Two Sigma Investments
New York
– -$79K -4,913 Closed
Northern Trust
39
Northern Trust
Illinois
– -$77.1K -4,797 Closed
Millennium Management
40
Millennium Management
New York
– -$66.1K -4,110 Closed
Dimensional Fund Advisors
41
Dimensional Fund Advisors
Texas
– -$51.8K -3,218 Closed
BAM
42
Berkshire Asset Management
Pennsylvania
– -$26.8K -1,667 Closed
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
– -$21K -1,333 Closed
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
– -$17.6K -1,095 Closed
SS
45
SBI Securities
Japan
– -$4 – –
XT
46
XTX Topco
Cayman Islands
– +$577K +43,534 +3,072%
1
2

IMA Hedge Fund Activity: Q3 2025 in Review

33 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2025, worth a combined $38.3M — down 9.9% from $42.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of IMA and 5 opened new positions — a net loss of 7 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Deep Track Capital, adding an estimated $8.87M. The largest seller was BML Capital Management, cutting an estimated $2.03M.

  • 33 institutional investors held ImageneBio Inc (IMA) as of Q3 2025, down from 40 in Q2 2025.
  • Funds reported $38.3M of ImageneBio Inc stock for Q3 2025, down 9.9% quarter-over-quarter.
  • 5 funds opened new ImageneBio Inc positions in Q3 2025 and 12 closed out, a net change of -7 holders.
  • The largest ImageneBio Inc buyer in Q3 2025 was Deep Track Capital, an estimated $8.87M added.
  • The largest ImageneBio Inc seller in Q3 2025 was BML Capital Management, an estimated $2.03M sold.

Based on aggregated 13F filings for Q3 2025.